Quiros-Roldan, E.; Amadasi, S.; Zanella, I.; Degli Antoni, M.; Storti, S.; Tiecco, G.; Castelli, F.
Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives. Pharmaceuticals 2021, 14, 1272.
https://doi.org/10.3390/ph14121272
AMA Style
Quiros-Roldan E, Amadasi S, Zanella I, Degli Antoni M, Storti S, Tiecco G, Castelli F.
Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives. Pharmaceuticals. 2021; 14(12):1272.
https://doi.org/10.3390/ph14121272
Chicago/Turabian Style
Quiros-Roldan, Eugenia, Silvia Amadasi, Isabella Zanella, Melania Degli Antoni, Samuele Storti, Giorgio Tiecco, and Francesco Castelli.
2021. "Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives" Pharmaceuticals 14, no. 12: 1272.
https://doi.org/10.3390/ph14121272
APA Style
Quiros-Roldan, E., Amadasi, S., Zanella, I., Degli Antoni, M., Storti, S., Tiecco, G., & Castelli, F.
(2021). Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives. Pharmaceuticals, 14(12), 1272.
https://doi.org/10.3390/ph14121272